Cart
sales@molnova.com
4SC-203
CAS No. 895533-09-2
4SC-203( —— )
Catalog No. M28711 CAS No. 895533-09-2
4SC-203 is a multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 155 | In Stock |
|
| 10MG | 250 | In Stock |
|
| 25MG | 440 | In Stock |
|
| 50MG | 607 | In Stock |
|
| 100MG | 863 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4SC-203
-
NoteResearch use only, not for human use.
-
Brief Description4SC-203 is a multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs).
-
Description4SC-203 is a multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFLT
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number895533-09-2
-
Formula Weight1283.53
-
Molecular FormulaC66H74N16O8S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (194.47 mM)
-
SMILESCc(cc1)cc(NC(Nc2nc(ccc(Nc(c3c4)ncnc3cc(OCCCN3CCN(C)CC3)c4OC)c3)c3s2)=O)c1OCCc(cc1)cc(NC(Nc2nc(ccc(Nc(c3c4)ncnc3cc(OCCCN3CCN(C)CC3)c4OC)c3)c3s2)=O)c1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bae Young-Soo, et al. Extractives of the Wood of Black Locust and the Bark of Poplar as Decay-Resistant Hardwood Tree Species. The Journal of veterinary medical science. 2000; 28(3): 52-61.
molnova catalog
related products
-
MRX-2843
MRX-2843 is a potent and orally active inhibitor of MERTK and FLT3(IC50s of 1.3 nM and 0.64 nM, respectively).
-
Pacritinib
Pacritinib (SB1518) is a potent and selective inhibitor of Janus Kinase 2 (JAK2) and Fms-Like Tyrosine Kinase-3 (FLT3) with IC50s of 23 and 22 nM in cell-free assays, respectively. Phase 3.
-
BGB-102
BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR and VEGFR3, which may be useful in the study of macular degeneration and diseases associated with genetic disorders and malformations.
